Companies: 10,795·Total market cap: $144.5T
CEL-SCI Corporation

CEL-SCI Corporation

CVMAMEXHealthcare● Active
$1.38
+$0.01(+0.73%)
Market Cap$9482790
P/E Ratio—
52W High$13.48
52W Low$0.89
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

CEL-SCI Corporation (CVM) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CVM · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-3.47cvm eps ttm · cvm earnings per shareEarnings history
PE Ratio (TTM)—cvm pe ratio ttm · cvm price to earningsPE Ratio deep dive
Revenue (TTM)0.00cvm revenue ttm · cvm annual revenueFull revenue history
Dividend Yield3.51%does cvm pay dividends · cvm dividend yieldDividend history
Shares Outstanding4.1Mcvm shares outstanding · cvm floatShares outstanding history
Next EarningsAug 17, 2026Est.cvm earnings date · cvm next earningsEarnings history

Explore CEL-SCI Corporation Data

cvm stock data · financials
Market Cap$9.5Mcvm market cap · cvm valuation
Analyst Forecast$— · Buy
Dividends3.51%does cel-sci corporation pay dividends · cvm dividend yield
Revenue—cel-sci corporation annual revenue · cvm revenue
EarningsEPS $-6.27+53.56%cvm earnings · cvm eps
PE Ratio—cvm pe ratio · cvm price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
cel-sci corporation revenue · cvm revenue 2025
FY 2025Net Income-$25.4M▲ +5.61% YoY
202320242025
cel-sci corporation net income · cvm profit 2025
FY 2025EPS$-6.27▲ +53.56% YoY
202320242025
cvm eps · cel-sci corporation earnings per share 2025
TTM:Revenue: $0.00Net Income: -$22.7MEPS: $-3.47View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy6 analystsis cvm a buy · cvm analyst rating
Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$1.38Current
$—Avg Target
$—High
cvm price target · cvm 12 month forecast

Total: 6 · Buy rate: 100.0%

Stock Performance

Full History
1D+0.73%
1W-8.00%
1M-18.82%
3M-64.34%
YTD-73.76%
1Y-54.75%
5Y-99.82%

About CEL-SCI Corporation

CEOGeert R. Kersten
IPO DateDec 8, 1983
Employees43
CountryUS
Websitecel-sci.com

CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is curren…

BiotechnologyHealthcareAMEXUS

what is cel-sci corporation · cvm stock overview · cel-sci corporation company profile · who is cel-sci corporation ceo · cvm AMEX · cel-sci corporation headquarters · cel-sci corporation business segments

About Stock Overview & Key Data

CEL-SCI Corporation (CVM) is a Healthcare company in the Biotechnology industry, listed on AMEX since Dec 8, 1983. As of the latest trading session, CVM stock price is $1.38, with a market capitalization of $9.5M. The stock has returned -54.75% over the past 12 months and -73.76% year-to-date.

According to 6 Wall Street analysts, the consensus rating for CEL-SCI Corporation stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, CEL-SCI Corporation reported revenue of — and net income of -$25.4M. For detailed data — including CEL-SCI Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CEL-SCI Corporation (CVM) stock price is $1.38. The stock is traded on AMEX under the ticker symbol CVM. The 52-week range is $0.89 – $13.48.

CVM stock priceCVM quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice